Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells

Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy

(2020) Barry E. Kennedy et al.   MOLECULAR THERAPY

Inhibition of pyruvate dehydrogenase kinase enhances the antitumor efficacy of oncolytic reovirus

(2019) Barry E Kennedy et al.   CANCER RESEARCH

Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool

(2019) Stefan Jordan et al.   CELL

Elevated Hexokinase II Expression Confers Acquired Resistance to 4-Hydroxytamoxifen in Breast Cancer Cells

(2019) Xiaochuan Liu et al.   MOLECULAR & CELLULAR PROTEOMICS

Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy

(2018) Xiao-Yan Zhang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer

(2018) Tingting Yang et al.   ONCOGENE

Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells

(2018) Arthur Dyer et al.   CANCER RESEARCH

Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53- deficiency-driven castration-resistant prostate cancer

(2016) Lei Wang et al.   EBioMedicine

439. Oncolytic Newcastle Disease Virus Iraqi Virulent Strain Induce Apoptosis In Vitro through intrinsic Pathway and Association of Both Intrinsic and Extrinsic Pathways In Vivo

(2015) Ahmed M. Al-Shammari et al.   MOLECULAR THERAPY

Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers

(2015) Ritu Arora et al.   Oncotarget

Proteomic analysis of chicken peripheral blood mononuclear cells after infection by Newcastle disease virus

(2014) Xiaoyu Deng et al.   Journal of Veterinary Science

Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment

(2014) D Ciavardelli et al.   Cell Death & Disease

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

(2013) Krushna C. Patra et al.   CANCER CELL

Hexokinase II in breast carcinoma: A potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67

(2013) Akiko Sato-Tadano et al.   CANCER SCIENCE

Targeting Hexokinase 2 May Block Cancer Glucose Metabolism

(2013)   Cancer Discovery

Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism

(2012) Yan Ding et al.   Nature Communications

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme

(2011) Amparo Wolf et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis

(2008) Maria Danos et al.   Biochemistry and Cell Biology